Skip to main content
Compliance

Appointed Representative vs Directly Authorised: Which Is Right for Your Brokerage?

By 21st April 2026July 23rd, 2026No Comments

When evaluating appointed representative vs directly authorised, one of the most consequential decisions you will face is how to obtain your regulatory permissions. Do you operate as an Appointed Representative (AR) under an existing firm’s umbrella, or do you pursue Direct Authorisation (DA) from the Financial Conduct Authority? Both routes are legitimate, widely used, and come with distinct advantages and trade-offs. Understanding appointed representative vs directly authorised is not just a compliance exercise, it is a strategic decision that shapes your business model, growth trajectory, and day-to-day operations.

What Does Each Model Actually Mean?

A Directly Authorised firm holds its own FCA authorisation. It applies directly to the regulator, is granted its own permissions, and takes full responsibility for regulatory obligations. The firm appears on the FCA register in its own right and is accountable to the FCA directly.

An Appointed Representative, by contrast, operates under the regulatory umbrella of a principal firm. This principal, already directly authorised, assumes responsibility for the AR’s conduct. While the AR is listed on the FCA register, the principal bears the compliance burden and liability. In practice, this means the principal’s systems, frameworks, and oversight processes dictate much of what the AR can and cannot do.

The Case for Becoming an Appointed Representative

In the appointed representative vs directly authorised debate, the AR model often appeals to newer or smaller brokerages. Speed is a major advantage. Direct FCA authorisation can take six months to over a year, whereas joining a principal network can allow you to begin trading within weeks.

Cost is another key factor. A directly authorised firm must invest in compliance infrastructure such as qualified compliance officers, policies and procedures, professional indemnity insurance, regulatory capital, and ongoing reporting. Under the AR model, much of this is handled by the principal in exchange for fees or revenue share, lowering the barrier to entry.

There’s also a practical learning benefit. Regulation is complex, and mistakes can be costly. Operating under a principal provides access to established compliance expertise, effectively acting as a support system while your business develops.

The AR route is particularly suited to brokerages with a narrow or specialised focus. If you don’t plan to expand product lines or operate independently in the near term, direct authorisation may be unnecessary overhead. 

The Case for Direct Authorisation

However, the appointed representative vs directly authorised comparison reveals a key limitation of the AR model: dependency.

As an AR, your permissions are tied to your principal. Expanding into new products or markets requires their approval, which can constrain growth. More importantly, your regulatory status depends on the principal’s stability; if they exit the market or change strategy, your business is immediately affected.

Direct authorisation removes this dependency. You own your permissions, control your strategy, and operate independently within FCA rules. This autonomy is crucial for firms with ambitious growth plans, diverse offerings, or long-term plans for investment or sale.

There’s also a reputational advantage. Larger clients, institutional partners, and professional introducers often view directly authorised firms as more established and credible.

Additionally, building your own compliance function creates internal expertise. Over time, this becomes a competitive advantage, enabling faster innovation, stronger governance, and less reliance on external providers.

Key Factors to Weigh

When deciding between appointed representative vs directly authorised, consider:

  • Stage of business: Early-stage firms often benefit from the lower cost and support of the AR model, while established firms are better positioned for DA.
  • Ambition and timeline: If you plan to scale or diversify within a few years, starting with direct authorisation may be more efficient.
  • Product scope: Broader offerings often require the flexibility that comes with direct authorisation.
  • Cost tolerance: AR models vary widely due diligence on the principal is essential.
  • Risk appetite: ARs share regulatory responsibility, while DA firms assume full control and accountability.

The Hybrid Path

The appointed representative vs directly authorised choice isn’t always permanent. Many brokerages begin as ARs, build revenue and experience, then transition to direct authorisation once they have the scale to support it. Firms that operate compliantly as ARs are often well-prepared for this transition.

Making the Right Call

There is no universal answer in the appointed representative vs directly authorised decision. The right path depends on your capital, ambitions, product complexity, and appetite for regulatory responsibility.

What matters is making a deliberate, informed choice, not defaulting to the easiest option. Both models can support successful, compliant businesses. The key question is: which one best supports the business you want to build?

This article is for informational purposes only and does not constitute legal or compliance advice. Brokers should consult their compliance function or a qualified regulatory adviser for guidance specific to their business.

Written by the Ecompli founder — With over 20 years in financial services and having founded Ecompli in 2006, these blogs are written by a specialist with hands-on expertise in FCA regulation across the mortgage, general insurance, equity release, and insurance claims handling sectors.